Stage III resectable NSCLC—especially N2 disease (ipsilateral mediastinal/subcarinal nodes) and multistation N2—has historically carried a poor prognosis, with high post-surgical relapse rates. CheckMate 77T previously established a perioperative benefit for […]
Want to stay in touch with the latest updates from Oncology News, Insights, Stories by OncoDaily? That's easy! Just subscribe clicking the Follow button below, choose topics or keywords for filtering if you want to, and we send the news to your inbox, to your phone via push notifications or we put them on your personal page here on follow.it.
Reading your RSS feed has never been easier!
Website title: Oncology News, Insights, Stories by OncoDaily
